Artos Analysis: $500K Raised
What is Artos?
Artos is an AI-driven platform for document creation and management in the life sciences sector, enhancing efficiency for biopharma companies in product market entry.
Product Features & Capabilities
- AI-powered document creation and management, end-to-end suite for INDs, NDAs, and BLAs, document drafting, custom templates, section regeneration, downstream visualization, source traceability, audit logs, search functionality, automated workflows, collaboration tools for medical writing, CMC, regul
Pricing
-
Basic Plan: $299 per year
- Designed for individuals or small teams
- 1-2 seats
- Drafting from fixed ICH template
- Redrafting
- Auto-references and hyperlinks
- Inconsistency tracking
-
Enterprise Plan: $999 per year
- Customized solutions for large enterprises
- Everyth
How much Artos raised
Pre-Seed - $500,000
March 27, 2024Lead Investor: Y Combinator
Who are the founders of Artos
JK
Josh Kim
CEO
VP
Varun Patel
CTO
Business Model
Subscription-based revenue model with a focus on AI-driven document management for life sciences.
Investors
- Y Combinator
- Horizon Venture Capital
- NVO Capital
- Phoenix Investment Club (San Francisco)
- Pioneer Fund
- Socii
Market Focus
Artos primarily focuses on the life sciences sector, specifically providing AI-powered solutions for document creation and management to help biopharma companies bring their products to market more efficiently and cost-effectively.
Competitors Overview
Artos operates in the life sciences sector, specifically focusing on AI-powered document creation and management for biopharma companies. Its main competitors include:
- ComplianceQuest: This platform offers comprehensive document management solutions tailored for the life sciences industry. I
See something that needs updating? Suggest edits to this profile.